T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease

Stem Cell Reports. 2018 Nov 13;11(5):1171-1184. doi: 10.1016/j.stemcr.2018.09.006. Epub 2018 Oct 18.

Abstract

Parkinson disease (PD) is a progressive neurological disease caused by selective degeneration of dopaminergic (DA) neurons in the substantia nigra. Although most cases of PD are sporadic cases, familial PD provides a versatile research model for basic mechanistic insights into the pathogenesis of PD. In this study, we generated DA neurons from PARK2 patient-specific, isogenic PARK2 null and PARK6 patient-specific induced pluripotent stem cells and found that these neurons exhibited more apoptosis and greater susceptibility to rotenone-induced mitochondrial stress. From phenotypic screening with an FDA-approved drug library, one voltage-gated calcium channel antagonist, benidipine, was found to suppress rotenone-induced apoptosis. Furthermore, we demonstrated the dysregulation of calcium homeostasis and increased susceptibility to rotenone-induced stress in PD, which is prevented by T-type calcium channel knockdown or antagonists. These findings suggest that calcium homeostasis in DA neurons might be a useful target for developing new drugs for PD patients.

Keywords: PARK2; Parkinson disease; T-type calcium channels; disease modeling; induced pluripotent stem cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Calcium / metabolism
  • Calcium Channel Blockers / chemistry
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, T-Type / metabolism*
  • Cell Line
  • Dopaminergic Neurons / metabolism
  • Dopaminergic Neurons / pathology*
  • Homeostasis / drug effects
  • Humans
  • Induced Pluripotent Stem Cells
  • Mitochondria / drug effects
  • Mitochondria / metabolism*
  • Models, Biological
  • Neuronal Outgrowth / drug effects
  • Neuroprotective Agents / pharmacology
  • Oxidative Stress* / drug effects
  • Parkinson Disease / metabolism*
  • Parkinson Disease / pathology*
  • Protein Kinases / metabolism
  • Rotenone / toxicity
  • Ubiquitin-Protein Ligases / metabolism

Substances

  • Calcium Channel Blockers
  • Calcium Channels, T-Type
  • Neuroprotective Agents
  • Rotenone
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Protein Kinases
  • PTEN-induced putative kinase
  • Calcium